Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The physiologic extracellular matrix (ECM) and adipose tissue compartments represent distinct yet interacting histological environments essential for tissue architecture and metabolic health. The ECM is a complex, dynamic scaffold of fibrous proteins, proteoglycans, and glycoproteins that regulates cell behavior, mechanical properties, and tissue homeostasis (NCBI, 2022). Adipose tissue functions as a specialized connective tissue and a major metabolic hub, storing lipids and acting as an endocrine organ by releasing hormones like leptin and adiponectin (StatPearls, 2023). These compartments are frequently implicated in the progression of chronic diseases, including systemic fibrosis, metabolic syndrome, and the tumor microenvironment, where they influence drug penetration and cellular resistance (PubMed, 2021). Because they are broad tissue classifications rather than discrete molecular entities, they are generally not classified as individual therapeutic targets. However, they contain numerous druggable proteins such as integrins, collagenases, and metabolic receptors that are targeted to treat specific pathologies. In pharmacological research, these compartments are primarily studied to understand drug distribution, bioavailability, and the impact of the microenvironment on therapeutic efficacy. Understanding the interplay between the ECM and adipose tissue is also crucial for regenerative medicine and tissue engineering applications.
Not applicable as this represents a tissue compartment or histological environment rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiologic extracellular matrix and adipose tissue compartments.